Dodgers (still) want to sign Pineiro

Leave a comment

The Los Angeles Dodgers want everyone to know they’re trying really, really hard. Honestly, folks.

According to Yahoo!’s Tim Brown, the Dodgers are trying to figure out away to sign free agent pitcher Joel Pineiro, who is coming off perhaps his finest season.

The Dodgers have reportedly been on the Pineiro hunt for awhile, but since it keeps coming up we’ll mention it again.

Following two straight trips to the NLCS, and proving to be no match for the Phillies in both instances, the Dodgers are taking an odd (meaning cheap) approach to this offseason. It’s an approach no doubt connected — no matter what the honchos tell you — to the ongoing divorce proceedings between owners Frank and Jamie McCourt.

The Dodgers have already let Randy Wolf walk and made little to no effort to bring back Jon Garland, Vicente Padilla and/or Jeff Weaver. Jason Schmidt is also gone, but his presence was little more than a rumor anyway, kind of like Sasquatch.

That leaves them with Chad Billingsley, Clayton Kershaw, Hiroki Kuroda and a host of other possibilities, including Hong-Chih Kuo, Eric Stults, James McDonald and Russ Ortiz. Russ Ortiz? What, Dave Burba wasn’t available?

Anyway, the whole thing is rather ridiculous considering the Dodgers said they couldn’t afford Wolf, who signed for three years and $29.75 million with the Brewers. Guess how much Pineiro wants? Three years, $30 million!

Who’s running that team, the body guard?

Follow me on Twitter at @bharks.

Jake Diekman will miss at least half of the 2017 season

TORONTO, ON - OCTOBER 9: Jake Diekman #41 of the Texas Rangers works against the Toronto Blue Jays in the sixth inning during game three of the American League Division Series at Rogers Centre on October 9, 2016 in Toronto, Canada. (Photo by Tom Szczerbowski/Getty Images)
Tom Szczerbowski/Getty Images
Leave a comment

Rangers reliever Jake Diekman will have surgery on January 25 to help alleviate ulcerative colitis, an inflammatory bowel disease. As a result, the lefty will miss at least half of the 2017 regular season, Jeff Wilson of the Fort Worth Star-Telegram reports. Diekman was diagnosed with the illness when he was 11 years old. He has brought awareness to the Crohn’s and Colitis Foundation of America with a “Gut It Out” campaign.

Diekman, who turns 30 years old on Saturday, finished the 2016 campaign with a 3.40 ERA and a 59/26 K/BB ratio in 53 innings. He came to the Rangers from the Phillies in the Cole Hamels trade on July 31, 2015.

The Rangers and Diekman avoided arbitration last Friday, agreeing to a $2.55 million salary for the 2017 season.

The Blue Jays and Bautista have reached a one year deal

TORONTO, ON - OCTOBER 19:  Jose Bautista #19 of the Toronto Blue Jays looks on during batting practice prior to game five of the American League Championship Series against the Cleveland Indians at Rogers Centre on October 19, 2016 in Toronto, Canada.  (Photo by Vaughn Ridley/Getty Images)
Getty Images
2 Comments

It’s been on the verge of happening for a few days now, but now it’s official: the Toronto Blue Jays and Jose Bautista have reached a one-year deal with a mutual option. The deal is pending physical. An announcement making the deal official is expected later in week.

The exact financial figures have not been disclosed, but Jon Heyman reports that it will be in excess of the $17.2 million Bautista turned down when he turned down the Jays’ qualifying offer.

Bautista had a tough 2016, hitting .234/.366/.452 with 22 home runs and 69 RBI, and some clubs likely considered a long-term deal for the 36-year-old too risky, this leading to the relative lack of reported interest in Bautista by other clubs. But back-to-back ALCS appearances by the Jays and the success and popularity Bautista has experienced in Toronto make his re-signing there a pretty sensible move for all involved.